This inventor holds 1 USPTO granted patent. Top assignees: Chinese Academy of Sciences, Yunnan University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: **Jianxin Pu: Innovator in Anti-HIV Compounds**
Introduction
Jianxin Pu is an accomplished inventor based in Kunming, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in developing compounds with potential anti-HIV properties. His innovative approach has resulted in a patent that showcases his dedication to finding effective solutions in medical science.
Latest Patents
Jianxin Pu holds a patent for his invention titled "Nitrogen-containing biphenyl compounds, pharmaceutical compositions of same, preparation methods and anti-HIV-1 uses thereof." This patent details nitrogen-containing biphenyl compounds as represented by a specific formula, along with their pharmaceutically acceptable salts or derivatives. The invention includes pharmaceutical compositions and the preparation methods thereof, highlighting the anti-HIV-1 uses of these compounds.
Career Highlights
Throughout his career, Jianxin Pu has collaborated with esteemed institutions such as the Chinese Academy of Sciences and Yunnan University. His roles in these organizations have allowed him to refine his research skills and innovate in the field of pharmaceuticals.
Collaborations
Jianxin Pu has had the opportunity to work alongside notable colleagues, including Jingping Liu and Handong Sun. These collaborations have further propelled his research efforts and contributed to the successful development of his patented compounds.
Conclusion
Jianxin Pu's contributions to pharmaceutical sciences, particularly in developing anti-HIV compounds, demonstrate his innovative spirit and commitment to addressing critical health challenges. His patent not only reflects his individual expertise but also highlights the importance of collaboration in advancing medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile